Medication info
Risedplus Tablet

Risedplus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201604677 · Approved 2016.07.29 · Insurance code 663607080

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week's supply of vitamin D at a daily dose of 800 IU. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Children and growing adolescents: Safety and efficacy have not been established.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary in older adults (60 years and older), as the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary in patients with a creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week's supply of vitamin D at a daily dose of 800 IU. If a patient forgets to take a dose on the scheduled day, they should take it on the day they remember. The next dose should be taken on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Children and growing adolescents: Safety and efficacy have not been established.

Precautions

This medication may irritate the lining of the stomach and esophagus, potentially leading to issues such as esophagitis or ulcer. If pain in the throat or chest or difficulty swallowing occurs after taking this medication, you should stop taking it immediately and consult a doctor. It should be taken with a sufficient amount of water, and you should not lie down for at least 30 minutes after taking it. This medication should not be given to patients with delayed esophageal clearance, severe renal impairment, or certain genetic disorders. Side effects such as gastrointestinal disturbances, bone pain, muscle pain, and skin rashes may occur during treatment. Report any unusual symptoms to your doctor. It is important to ensure adequate intake of calcium and vitamin D during treatment, and supplements should be taken if necessary. Additionally, this medication may interfere with absorption when taken with food or other medications containing calcium or magnesium, so it is important to manage the timing of doses. Caution is required when using this medication during pregnancy or breastfeeding, and the decision should be made after consulting a doctor. It is advisable not to use this medication in children, as safety and efficacy have not been adequately established. In cases of overdose, symptoms of hypocalcemia may occur, and immediate medical assistance should be sought. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • dysphagia
  • odynophagia
  • retrosternal pain
  • heartburn
Show 119 more
  • gastric ulcer
  • duodenal ulcer
  • infection
  • low back pain
  • pain
  • abdominal pain
  • neck pain
  • fatigue
  • chest pain
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • dizziness
  • hypertonia
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataracts
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • duodenitis
  • glossitis
  • hypocalcemia
  • hypophosphatemia
  • fever
  • epidemic cold syndrome
  • headache
  • injury due to an accident
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • myopathy
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • chest burning
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • facial swelling
  • hair loss
  • altered smell
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blistering
  • jaw necrosis
  • liver dysfunction
  • jaundice
  • external auditory canal osteonecrosis
  • atypical fracture
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • anorexia
  • dry mouth
  • influenza
  • nasopharyngitis
  • bronchitis
  • gastroenteritis
  • upper respiratory tract inflammation
  • osteoarthritis
  • limb pain
  • muscle rigidity
  • cervical pain
  • myasthenia
  • falling
  • dizziness
  • hypercholesterolemia
  • cough
  • depression

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.